Turkey versus guinea pig red blood cells: Hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1

Viral Immunology

Volumn 27, Issue 4, 2014, Pages 174-178

  Ovsyannikova, Inna G ^a   White, Sarah J ^a,c   Albrecht, Randy A ^b   García Sastre, Adolfo ^b   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ARKANSAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY TITER; ARTICLE; ERYTHROCYTE; GUINEA PIG; HEMAGGLUTINATION INHIBITION; HUMAN; HUMORAL IMMUNITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NONHUMAN; SEROCONVERSION; TURKEY (BIRD); ANIMAL; COMPARATIVE STUDY; EVALUATION STUDY; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; VIROLOGY;

AGED; ANIMALS; ERYTHROCYTES; GUINEA PIGS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTINATION, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MIDDLE AGED; TURKEYS;

EID: 84900557764     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2013.0111     Document Type: Article

References (26)

1. Barr IG, McCauley J, Cox N, et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 2010; 28: 1156-1167.
2. Baum LG, and Paulson JC. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl 1990; 40: 35-38.
3. Brydak LB, and Machala M. Humoral immune response to influenza vaccination in patients from high risk groups. Drugs 2000; 60: 35-53.
4. Connor RJ, Kawaoka Y, Webster RG, and Paulson JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994; 205: 17-23.
5. Couceiro JN, Paulson JC, and Baum LG. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res 1993; 29: 155-165.
6. Coudeville L, Bailleux F, Riche B, Megas F, Andre P, and Ecochard R. Relationship between haemagglutinationinhibiting antibody titres and clinical protection against influenza: development and application of a bayesian randomeffects model. BMC Med Res Methodol 2010; 10: 18.
7. de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, and Osterhaus AD. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003; 115: 63-73.
8. Ducatez MF, Cai Z, Peiris M, et al. Extent of antigenic cross-reactivity among highly pathogenic H5N1 influenza viruses. J Clin Microbiol 2011; 49: 3531-3536.
9. Imai M, and Kawaoka Y. The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol 2012; 2: 160-167.
10. Ito T, Suzuki Y, Mitnaul L, Vines A, Kida H, and Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997; 227: 493-499.
11. Katz JM, Hancock K, and Xu X. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther 2011; 9: 669-683.
12. Lowen AC, Steel J, Mubareka S, Carnero E, Garcia-Sastre A, and Palese P. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J Virol 2009; 83: 2803-2818.
13. Makkoch J, Prachayangprecha S, Payungporn S, et al. Erythrocyte binding preference of human pandemic influenza virus a and its effect on antibody response detection. Ann Lab Med 2012; 32: 276-282.
14. Nam JH, Kim EH, Song D, Choi YK, Kim JK, and Poo H. Emergence ofmammalian species-infectious and -pathogenic avian influenza H6N5 virus with no evidence of adaptation. J Virol 2011; 85: 13271-13277.
15. Paulson JC, and Rogers GN. Resialylated erythrocytes for assessment of the specificity of sialyloligosaccharide binding proteins. Methods Enzymol 1987; 138: 162-168.
16. Rogers GN, and Paulson JC. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983; 127: 361-373.
17. Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999; 37: 937-943.
18. Ryan-Poirier KA, and Kawaoka Y. Distinct glycoprotein inhibitors of influenza A virus in different animal sera. J Virol 1991; 65: 389-395.
19. Skehel JJ, and Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000; 69: 531-569.
20. Stephenson I, Wood JM, Nicholson KG, and Zambon MC. Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol 2003; 70: 391-398.
21. Thompson CI, Barclay WS, and Zambon MC. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. J Antimicrob Chemother 2004; 53: 759-765.
22. Wang S, Taaffe J, Parker C, et al. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codonoptimized HA DNA vaccines. J Virol 2006; 80: 11628-11637.
23. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, and Wiley DC. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 1988; 333: 426-431.
24. World Health Organization. 2002. WHO Manual on Animal Influenza Diagnosis and Surveillance, pp. 1-99.
25. World Health Organization. 2009. Influenza (Seasonal). www.who.int/mediacentre/factsheets/fs211/en/. Accessed March 20, 2013.
26. World Health Organization. 2011. WHO Global Influenza Surveillance Network: Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza, pp. 1-139.